Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000246208

Medchemexpress LLC Msx-127 | 6616-56-4 | 99.7% | 308.37 g/mol | C16H24N2O4 | 50 MG
SDP

Catalog No. 5000246208
Encompass_Preferred

MSX-127 is a small-molecule CXCR4 antagonist used in preclinical research to study CXCR4-mediated signaling and the inhibition of cancer metastasis. Supplied as a high-purity solid for laboratory use; not for human or veterinary use.

  • Small-molecule CXCR4 antagonist for receptor signaling studies.
  • Used to investigate cancer metastasis and tumor cell migration.
  • Purity 99.7% as reported by the supplier.
  • Molecular weight 308.37 g/mol; formula C16H24N2O4.
  • CAS number 6616-56-4 for compound identification.
  • Supplied as a 50 mg solid for laboratory research.
  • For research use only; not for human or veterinary use.

Catalog No. 50-002-46208 Supplier Medchemexpress LLC Supplier No. HY10300950MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

MSX-127 is a small-molecule CXCR4 antagonist used in preclinical research to study CXCR4-mediated signaling and the inhibition of cancer metastasis. Supplied as a high-purity solid for laboratory use; not for human or veterinary use.

  • Small-molecule CXCR4 antagonist for receptor signaling studies.
  • Used to investigate cancer metastasis and tumor cell migration.
  • Purity 99.7% as reported by the supplier.
  • Molecular weight 308.37 g/mol; formula C16H24N2O4.
  • CAS number 6616-56-4 for compound identification.
  • Supplied as a 50 mg solid for laboratory research.
  • For research use only; not for human or veterinary use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.